Real Barriers to Vaccine Equity: Low Demand & Inability to AdministerMay 17, 2022
The world has made great progress in the battle against COVID-19, including the development of lifesaving vaccines. This progress has been supported by robust IP protections that continue to power innovations. As we work to turn the page on the pandemic, it’s crucial we both continue to protect IP and address the real barriers hampering equitable vaccine efforts. Our latest blog explains how issues like low demand and an inability to administer doses must be met to ensure greater vaccine equity for all.